id-hub.com
The APPROACH clinical trial produces positive results with a mosaic HIV-1 vaccine - Infectious Diseases Hub
Experimental HIV-1 vaccine regimen Ad26.Mos.HIV is safe and elicits a robust immune response according to results of a Phase I/IIa clinical trial.